The colon, inflammatory bowel disease, & infectious diseases - Update in medical treatment of Crohn's disease

被引:11
|
作者
Regueiro, MD [1 ]
机构
[1] Univ Pittsburgh, Med Ctr, Div Gastroenterol Hepatol & Nutr, Inflammatory Bowel Dis Program,Dept Internal Med, Pittsburgh, PA 15213 USA
关键词
Crohn's disease; inflammatory bowel disease; treatment;
D O I
10.1097/00004836-200012000-00004
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Crohn's disease is an inflammatory bowel disorder that has no known cause. The goal of medical treatment is to control active disease, induce and maintain clinical remission, and treat complications. Anti-inflammatory medications and immunomodulatory therapies are the primary treatment modalities for Crohn's disease. The categories of standard treatment include the 5-aminosalicylic acid compounds, corticosteroids, antibiotics, and immunomodulators. New biologic therapy has been developed to better target the immune mediators that are active in Crohn's disease. Infliximab is the first of the biologic agents approved for the treatment of fistulizing and active Crohn's disease. Despite medical advances in treatment, there is still no cure for Crohn's disease.
引用
收藏
页码:282 / 291
页数:10
相关论文
共 50 条
  • [1] An update on the medical treatment of Crohn's disease
    Valentini, G
    Guidi, L
    Costanzo, M
    Ciarniello, M
    De Vitis, I
    Capristo, E
    Fedeli, G
    [J]. PANMINERVA MEDICA, 2003, 45 (01) : 15 - 22
  • [2] Infectious inflammatory bowel diseases and Leoeniowski-Crohn's disease - diagnostic and therapeutic problems
    Piascik, Marta
    Pawlik, Magdalena
    Rydzewska, Grazyna
    [J]. PRZEGLAD GASTROENTEROLOGICZNY, 2006, 1 (02): : 88 - 91
  • [3] Chronic inflammatory Bowel Diseases Ustekinumab in Crohn's disease?
    Pommer, Peter
    [J]. ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2013, 51 (06): : 523 - 523
  • [4] Inflammatory bowel diseases. Crohn's disease and ulcerative colitis
    Fischer, S.
    Rath, T.
    Neurath, M. F.
    [J]. INTERNIST, 2018, 59 (07): : 681 - 692
  • [5] Inflammatory Bowel Diseases (Crohn's Disease and Ulcerative Colitis): Cost of Treatment in Serbia and the Implications
    Kostic, Marina
    Djakovic, Ljiljan
    Sujic, Rasa
    Godman, Brian
    Jankovic, Slobodan M.
    [J]. APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 2017, 15 (01) : 85 - 93
  • [6] Inflammatory Bowel Diseases (Crohn´s Disease and Ulcerative Colitis): Cost of Treatment in Serbia and the Implications
    Marina Kostić
    Ljiljan Djakovic
    Raša Šujić
    Brian Godman
    Slobodan M. Janković
    [J]. Applied Health Economics and Health Policy, 2017, 15 : 85 - 93
  • [7] Update in medical therapy in inflammatory bowel disease: A clinician's view
    Katz, S
    [J]. DIGESTIVE DISEASES, 1999, 17 (03) : 163 - 171
  • [8] Colonic inflammatory bowel disease - Medical therapie's for colonic Crohn's disease and ulcerative colitis
    Tung, JK
    Warner, AS
    [J]. POSTGRADUATE MEDICINE, 2002, 112 (05) : 45 - +
  • [9] Experimental Inflammatory Bowel Disease: Lessons for the Treatment of Crohn's Disease and Ulcerative Colitis
    Ivan Fuss
    [J]. Pediatric Research, 1999, 45 : 746 - 746
  • [10] Interdisciplinary guidelines: Inflammatory bowel diseases - Crohn's disease, ulcerative colitis
    Caspary, WF
    [J]. EFFICIENCY AND ECONOMICS OF CLINICAL CARE AND RESEARCH IN SURGERY, 1997, SUPPL : 100 - 108